IT Risk Management. Agenda. Roche at a glance OSI Layers above 7 What we did What we plan to do how to not get shoot

Size: px
Start display at page:

Download "IT Risk Management. Agenda. Roche at a glance OSI Layers above 7 What we did What we plan to do how to not get shoot"

Transcription

1 IT Risk Management ISACA Switzerland Chapter After Hours Seminar Mario Walter Agenda Roche at a glance OSI Layers above 7 What we did What we plan to do how to not get shoot 2006 ISACA After Hours Seminar IT Risk Management Mario Walter Seite 2

2 Corporate Setup Clear focus on innovating healthcare Two strong pillars Roche: Since 2004 healthcare company focused on pharmaceuticals and diagnostics Roche Diagnostics: A global leader in diagnostics Roche Pharmaceuticals: A global leader in biotechnology and key therapeutic areas 2006 ISACA After Hours Seminar IT Risk Management Mario Walter Seite 3 Basic facts Founded 1896 in Basel, Switzerland Employing around people Currently active in 150 countries on all continents 2005 sales (continuing businesses): 35.5 billion Swiss Francs Core businesses: Pharmaceuticals and Diagnostics Number 1 in the global diagnostics market (in vitro), the leading supplier of medicines for cancer & transplantation and a market leader in virology 2006 ISACA After Hours Seminar IT Risk Management Mario Walter Seite 4

3 Corporate Setup Roche Group Sales % local 20 % CHF in CHF m 25 % 26 % 4% 5 % ISACA After Hours Seminar IT Risk Management Mario Walter Seite 5 Roche strategy Innovation across the entire healthcare-spectrum Our capabilities in diagnostics and pharmaceuticals enable us to innovate across the entire healthcare spectrum, from identifying disease susceptibilities and disease screening in populations at risk to prevention, diagnosis, therapy and treatment monitoring. Predisposition Early detection Prevention Diagnosis Therapy Monitoring 2006 ISACA After Hours Seminar IT Risk Management Mario Walter Seite 6

4 Diagnostics Division Diagnostics market Market share 1 Sales growth 2 Roche Diagnostics Abbott J & J Bayer* Beckman C.* Dade Behring * DIA Market ** 1 Source: company reports, Boston Biomedical Consultants, Roche analysis 2 in local currencies; excludes Life Science research market * Based on nine months sales 2004 **IVD 2006 ISACA After Hours Seminar IT Risk Management Mario Walter Seite 7 Diagnostics Division Broadest product portfolio in the industry Life science research Diagnostics market Research Professionals Consumers research academia pharma biotech university hospital commercial lab hospital clinic GP patient Applied Science Molecular Diagnostics Centralized Diagnostics Near Patient Testing Diabetes Care 2006 ISACA After Hours Seminar IT Risk Management Mario Walter Seite 8

5 Diagnostics broadest portfolio Molecular Biochemicals Molecular Systems Clinical Chemistry Immunology Haematology Coagulation Blood Glucose Testing Urinanalysis Point of Care Blood gas/ electrolytes LightCycler, MagNA Pure LC COBAS AMPLICOR, AmpliScreen, AmpliPrep, TaqMan Roche/Hitachi and COBAS INTEGRA lines Elecsys and E170 (MODULAR ANALYTICS SWA) Sysmex systems STA-R, STA Compact, STA-R Evolution Products of the Accu-Chek family Miditron, Combur product line, Urisys CoaguChek, Cardiac Reader, Reflotron OMNI C/S COBAS, INTEGRA, ELECSYS, MIDITRON, MODULAR and URISYS are trademarks of Roche. STA and STA Compact are trademarks of Diagnostica STAGO S.A ISACA After Hours Seminar IT Risk Management Mario Walter Seite 9 Diagnostics Division Regional headquarters and R&D centers Indianapolis Pleasanton/ Alameda Rotkreuz Basel Burgdorf Mannheim Penzberg Graz Tokyo Applied Science Molecular Diagnostics Centralized Diagnostics Near Patient Testing Diabetes Care Branchburg Barcelona Singapore Regional headquarters 2006 ISACA After Hours Seminar IT Risk Management Mario Walter Seite 10

6 Agenda Roche at a glance OSI Layers above 7 What we did What we plan to do how to not get shoot 2006 ISACA After Hours Seminar IT Risk Management Mario Walter Seite 11 OSI Modell 2006 ISACA After Hours Seminar IT Risk Management Mario Walter Seite 12

7 The layers above 7 Layer 10 Regulations Layer 9 Finance Layer 8 Politics 2006 ISACA After Hours Seminar IT Risk Management Mario Walter Seite 13 Agenda Roche at a glance OSI Layers above 7 What we did so far What we plan to do how to not get shoot 2006 ISACA After Hours Seminar IT Risk Management Mario Walter Seite 14

8 E Frequent ~ 1 per day D Probable ~ every 10 days C Occasional ~ 3 times a year B Remote ~ once in 3 years A Improbable ~ once in 30 years Minor 2 Moderate 3 Considerable 4 Critical 5 Catastrophic How to tackle risks Strategic approach Probability 1 Severity Risk Operational approach Correlation 2006 ISACA After Hours Seminar IT Risk Management Mario Walter Seite 15 Strategic approach - The Project Global IT Security launched a project to: develop a comprehensive overview of all potential relevant IT risk scenarios throughout Roche Diagnostics systematically collect and assess the top major risk scenarios related to IT security present all collected information on IT risk scenarios in one single picture, i.e. the IT Risk Landscape as a sound basis for decision making define a top-down approach for improving IT security based on the high level IT Risk Landscape enable an optimal balance between accepting/mitigating risks and prioritization, resource allocation, timing, impact 2006 ISACA After Hours Seminar IT Risk Management Mario Walter Seite 16

9 Method A team of internal and external IT security experts systematically collected, described and evaluated Roche Diagnostics specific IT risk scenarios Elaborated the risk ratings (i.e. frequency and severity), based on professional judgment mapped the risk scenarios to operational risk management standards, e.g. COSO chose not extreme but realistic scenarios that could happen here and now organized a security-internal quality assurance with the DISN, the Diagnostics Information Security Network, team members developed a process for periodic update/maintenance of the IT Risk Landscape 2006 ISACA After Hours Seminar IT Risk Management Mario Walter Seite 17 The IT Risk Landscape Probability E Frequent ~ 1 per day D Probable ~ every 10 days C Occasional ~ 3 times a year b B Remote ~ once in 3 years a A Improbable ~ once in 30 years Minor 2 Moderate 3 Considerable 4 Critical 5 Catastrophic Severity 2006 ISACA After Hours Seminar IT Risk Management Mario Walter Seite 18

10 Security Operations Competency Center (SOCC) Overall Strategy: Integrated View supports risk management Impact Analysis. Threat Profile. Reduction falsepositives IDS Detection VM Correlation Log Files Prevention 2006 ISACA After Hours Seminar IT Risk Management Mario Walter Seite 19 Current Supported Services Detection and Prevention (Network) Global Pharmaceuticals Global Diagnostics 1 FTE 1 FTE Roche Global Security Operations and Competency Center Personal Firewall (Desktop) Global Diagnostics 1 FTE Vulnerability Management Global Pharmaceuticals Global Diagnostics 1 FTE 1 FTE 16 Hours Manned Coverage 7x24 on-call coverage 365 Days Per Year 2006 ISACA After Hours Seminar IT Risk Management Mario Walter Seite 20

11 Agenda Roche at a glance OSI Layers above 7 What we did so far What we plan to do how to not get shoot 2006 ISACA After Hours Seminar IT Risk Management Mario Walter Seite 21 A Single Integrated Solution Monitoring, Visualization, and Reporting Real-time Analysis, Correlation, and Workflow Event Collectors Firewalls Firewalls Detection Applications Firewalls Firewalls Systems Detection Applications Detection Applications Firewalls Systems Detection Systems Hosts Applications Applications Systems Applications Applications Detection Anti Systems Detection Detection Detection Virus Anti Systems Detection Systems Detection Detection Systems Detection Systems Detection Network Systems Systems Databases Virus Systems Equipment Systems Sign-On Sign-On Directory Services 2006 ISACA After Hours Seminar IT Risk Management Mario Walter Seite 22

12 A roadmap Provide senior management with traffic lights Complexity / Integration Create dashboards for your management Define a scoring system Time 2006 ISACA After Hours Seminar IT Risk Management Mario Walter Seite 23 Agenda Roche at a glance OSI Layers above 7 What we did so far What we plan to do how to not get shot 2006 ISACA After Hours Seminar IT Risk Management Mario Walter Seite 24

13 5 body armour points Start small Convince / seduce your senior management Get a strong relationship with your operational people Be aware that people fear the new Be supportive, i.e. help projects achieve their goals 2006 ISACA After Hours Seminar IT Risk Management Mario Walter Seite 25 Questions 2006 ISACA After Hours Seminar IT Risk Management Mario Walter Seite 26

Accu-Chek Inform II system. Professional glucose testing for the wireless age

Accu-Chek Inform II system. Professional glucose testing for the wireless age Accu-Chek Inform II system Professional glucose testing for the wireless age The Accu-Chek Inform II system Real time control The Accu-Chek Inform II System overview Quality Advanced chemistry with multiple

More information

Bettina Marcinkowski, Roche Diagnostics GmbH

Bettina Marcinkowski, Roche Diagnostics GmbH Roche an attractive employer Academic Recruiting, Career Services & Employer Branding Munich, February 27, 2012 Bettina Marcinkowski, Roche Diagnostics GmbH To share with you Passionate about recruiting

More information

Connecting solutions of excellence

Connecting solutions of excellence MODULAR PRE-ANALYTICS EVO analyzer Connecting solutions of excellence COBAS, COBAS C, COBAS E, COBAS P, LIFE NEEDS ANSWERS, MODULAR ANALYTICS EVO, MODULAR PRE-ANALYTICS EVO, MODULAR, ELECSYS and COBAS

More information

Roche Support Network. Dependable technical, clinical and IT support delivered by experts who know your business

Roche Support Network. Dependable technical, clinical and IT support delivered by experts who know your business Roche Support Network Dependable technical, clinical and IT support delivered by experts who know your business Support you feel, but don t always see Solutions to optimize every aspect of your laboratory

More information

Proactive recruitment and sourcing at Roche April 2014. Wiebke Bräuer

Proactive recruitment and sourcing at Roche April 2014. Wiebke Bräuer Proactive recruitment and sourcing at Roche April 2014 Wiebke Bräuer Basic facts at a glance Founded 1896 in Basel, Switzerland Founding families still hold majority stake Employing 85,000 people Currently

More information

Nine-month sales show continued double-digit growth significantly above the market average

Nine-month sales show continued double-digit growth significantly above the market average Investor Update Basel, 14 October 2004 Nine-month sales show continued double-digit growth significantly above the market average Roche Group Sales in core businesses up by 14%* to 21.9 billion Swiss francs

More information

Roche Diagnostics Driving Personalized Healthcare

Roche Diagnostics Driving Personalized Healthcare r his presentation contains certain forward-looking statements. hese forward-looking statements may be identified by words such as believes, expects, anticipates, projects, intends, should, seeks, estimates,

More information

Media Release. Basel, 11 June 2009. RA patients with enhanced response identified

Media Release. Basel, 11 June 2009. RA patients with enhanced response identified Media Release Basel, 11 June 2009 New data demonstrate the ability of MabThera to reduce the progression of joint damage when used as a first-line biologic treatment in rheumatoid arthritis RA patients

More information

The Roche HR Experience Map. Christine Renz Head of Attraction, Sourcing & Hiring Roche Basel

The Roche HR Experience Map. Christine Renz Head of Attraction, Sourcing & Hiring Roche Basel The Roche HR Experience Map Christine Renz Head of Attraction, Sourcing & Hiring Roche Basel Roche at a glance Founded 1896 in Basel, Switzerland Founding families still hold majority stake Employing 85,000

More information

Background Information

Background Information Background Information r One About NAT Testing NAT testing has been widely embraced by laboratories throughout the world as a means to identify CT cases because of its high degree of accuracy and reliability

More information

91,747 employees in over 100 countries

91,747 employees in over 100 countries Roche in Brief 2015 Roche Who we are Who we are Roche Who we are 91,747 employees in over 100 countries CHF 48.1 bn in Group sales in 2015 # 1 in biotech, oncology, in vitro diagnostics and hospital market

More information

Diagnostics Division. Roland Diggelmann COO Roche Diagnostics. Picture

Diagnostics Division. Roland Diggelmann COO Roche Diagnostics. Picture Diagnostics Division Roland Diggelmann COO Roche Diagnostics Picture HY 2013: Roche Group highlights HY 2013 performance Strong Pharma performance, driven by US; solid growth for Diagnostics 12% core EPS

More information

F. Hoffmann-La Roche AG chooses enteo NetInstall to manage software packaging and distribution

F. Hoffmann-La Roche AG chooses enteo NetInstall to manage software packaging and distribution enteo I success story GLOBAL DISTRIBUTION F. Hoffmann-La Roche AG chooses enteo NetInstall to manage software packaging and distribution Global structures require global management. Central administration

More information

Worldwide Markets and Emerging Technologies for Point-of-Care Testing, 2013-2019. February 2015

Worldwide Markets and Emerging Technologies for Point-of-Care Testing, 2013-2019. February 2015 Worldwide Markets and Emerging Technologies for Point-of-Care Testing, 2013-2019 February 2015 INTELAB CORPORATION MARKET AND TECHNOLOGY REPORTS Report 530 Copyright 2015 Worldwide Markets and Emerging

More information

Roche facts & figures for U.S. investors

Roche facts & figures for U.S. investors Roche facts & figures for U.S. investors About Roche Founded in 1896, headquartered in Basel, Switzerland, Roche is a leader in research-focused healthcare with combined strengths in pharmaceuticals and

More information

Committed to innovation and growth

Committed to innovation and growth Committed to innovation and growth Alan Hippe, CFO Roche Group London, September 2012 This presentation contains certain forward-looking statements. These forward-looking statements may be identified by

More information

Products and Solutions 2015 Roche Diagnostics

Products and Solutions 2015 Roche Diagnostics Products and Solutions 2015 Roche Diagnostics I i I a I i healthy At Roche Diagnostics, we re giving you the answers today for a healthier tomorrow. We give you The Power of Knowing Diseases raise many

More information

Roche in Switzerland Innovation is our home

Roche in Switzerland Innovation is our home Roche in Switzerland Innovation is our home Roche s sites in Switzerland in context Roche was founded by Fritz Hoffmann-La Roche on 1 October 1896. He was one of the first people to recognise that major

More information

Abbott Diagnostics. Durable Growth Business

Abbott Diagnostics. Durable Growth Business Abbott Diagnostics Durable Growth Business Forward-Looking Statement Some statements in this presentation may be forward-looking statements for purposes of the Private Securities Litigation Reform Act

More information

WAN security threat landscape and best mitigation practices. Rex Stover Vice President, Americas, Enterprise & ICP Sales

WAN security threat landscape and best mitigation practices. Rex Stover Vice President, Americas, Enterprise & ICP Sales WAN security threat landscape and best mitigation practices. Rex Stover Vice President, Americas, Enterprise & ICP Sales The Cost of Cybercrime Sony $171m PlayStation 3 data breach (April 2011) $3 trillion

More information

Welcome to Penzberg. One of Europe s largest biotech facilities

Welcome to Penzberg. One of Europe s largest biotech facilities Welcome to Penzbeg One of Euope s lagest biotech facilities The Roche Goup s lagest biotech facility The Penzbeg site Pofile Role Diagnostics Phamaceuticals Futue Whee it all began The Penzbeg site in

More information

FACULTY OF ALLIED HEALTH SCIENCES

FACULTY OF ALLIED HEALTH SCIENCES FACULTY OF ALLIED HEALTH SCIENCES 102 Naresuan University FACULTY OF ALLIED HEALTH SCIENCES has focused on providing strong professional programs, including Medical established as one of the leading institutes

More information

Selling into Life Science Research 2020 The ecommerce shift

Selling into Life Science Research 2020 The ecommerce shift www.pwc.com Selling into Life Science Research 2020 The ecommerce shift Dr. Nikolas Beutin Dr. David Pumberger Agenda Page 1 Today s Life Science Research Market 1 2 The ecommerce shift 5 3 Way forward

More information

Enabling Superior Manufacturing Performance with SAP ERP and SAP xmii at Roche Robert Fretz

Enabling Superior Manufacturing Performance with SAP ERP and SAP xmii at Roche Robert Fretz Enabling Superior Manufacturing Performance with SAP ERP and SAP xmii at Roche Robert Fretz Head of Process Automation & MES Roche Pharmaceutical Division Company Background and Challenges Business Considerations

More information

SMF Awareness Seminar 2014

SMF Awareness Seminar 2014 SMF Awareness Seminar 2014 Clinical Evaluation for In Vitro Diagnostic Medical Devices Dr Jiang Naxin Health Sciences Authority Medical Device Branch 1 In vitro diagnostic product means Definition of IVD

More information

Manufacturing CUSTOM CHEMICALS AND SERVICES, SUPPORTING SCIENTIFIC ADVANCES FOR HUMAN HEALTH

Manufacturing CUSTOM CHEMICALS AND SERVICES, SUPPORTING SCIENTIFIC ADVANCES FOR HUMAN HEALTH Manufacturing CUSTOM CHEMICALS AND SERVICES, SUPPORTING SCIENTIFIC ADVANCES FOR HUMAN HEALTH VWR enables the advancement of science by providing high-quality chemicals and services, customized to your

More information

Text Mining in a Pharmaceutical Company

Text Mining in a Pharmaceutical Company Not for redistribution Text Mining in a Pharmaceutical Company Carola Lefrank, Roche Innovation Center Basel Bern, June 2015 About Us Use of Text Mining Negotiation Challenges Commercial Services Summary

More information

Roche for better patient care in kidney disease

Roche for better patient care in kidney disease Roche for better patient care in kidney disease Kidney disease and its growing importance Chronic kidney disease is a serious condition affecting roughly 10% of the adult population 1, many of whom remain

More information

EiCon G.m.b.H. Diagnostic Healthcare Consulting. Amtsgericht Lörrach : HRB-Nr.3002. E-Mail : info@eiconnet.de. Home page: http://www.eiconnet.

EiCon G.m.b.H. Diagnostic Healthcare Consulting. Amtsgericht Lörrach : HRB-Nr.3002. E-Mail : info@eiconnet.de. Home page: http://www.eiconnet. EiCon G.m.b.H. Diagnostic Healthcare Consulting Amtsgericht Lörrach : HRB-Nr.3002 Unterbaselweg 55 D -79576 Weil am Rhein Germany Phone : (49) - 7621-798373 Fax : (49) - 7621-798374 Hauptstrasse 160 D-79576

More information

Global Monoclonal Antibodies Pipeline Insight 2015

Global Monoclonal Antibodies Pipeline Insight 2015 Brochure More information from http://www.researchandmarkets.com/reports/3113388/ Global Monoclonal Antibodies Pipeline Insight 2015 Description: Ever since the Nobel Prize was bestowed on the person who

More information

FDA grants Roche s Perjeta regimen Priority Review for use before surgery in HER2-positive early-stage breast cancer

FDA grants Roche s Perjeta regimen Priority Review for use before surgery in HER2-positive early-stage breast cancer Media Release Basel, 2 July, 2013 FDA grants Roche s Perjeta regimen Priority Review for use before surgery in HER2-positive early-stage breast cancer Application follows proposed new FDA pathway designed

More information

Roche Turkey Corporate Responsibility Report 2013. Improving lives - now and in the future

Roche Turkey Corporate Responsibility Report 2013. Improving lives - now and in the future Roche Turkey Corporate Responsibility Report 2013 Improving lives - now and in the future Highlights of 2013 DJSI industry leader for the fifth time in a row High levels maintained in ethics and compliance

More information

Innovation, Speed and Growth: Hoffmann-La Roche in the Pharmaceutical Industry

Innovation, Speed and Growth: Hoffmann-La Roche in the Pharmaceutical Industry Innovation, Speed and Growth: Hoffmann-La Roche in the Pharmaceutical Industry CPM spoke recently with Ronnie Miller about how Hoffmann-La Roche stays on the cutting edge of the industry, and about Hoffmann-La

More information

Careers in the Pharmaceutical Industry - what really counts - Dr. Wolfgang Haupt Novartis Vaccines & Diagnostics, Marburg, Germany

Careers in the Pharmaceutical Industry - what really counts - Dr. Wolfgang Haupt Novartis Vaccines & Diagnostics, Marburg, Germany Careers in the Pharmaceutical Industry - what really counts - Dr. Wolfgang Haupt Novartis Vaccines & Diagnostics, Marburg, Germany Agenda Section 1 Overview on the Top Ten Pharmaceutical Companies Section

More information

Centro de Salud México España Centro de Salud San Francisco Culhuacán Mexico City, Mexico

Centro de Salud México España Centro de Salud San Francisco Culhuacán Mexico City, Mexico Centro de Salud México España Centro de Salud San Francisco Culhuacán Mexico City, Mexico Mexico City is one of the largest cities in the world and home to over 21 million people. The population is culturally

More information

Innovative people need room to breathe

Innovative people need room to breathe 92/93 Arthur D. Little How important is the protection of intellectual property to sustaining innovation in your business? Schwan Without patents there would be no innovation in our industry. Patents are

More information

MSc in Toxicology. Master Degree Programme

MSc in Toxicology. Master Degree Programme Master Degree Programme MSc in Toxicology Department of Pharmaceutical Sciences, University of Basel Swiss Centre for Applied Human Toxicology (SCAHT) Master of Science in Toxicology University of Basel

More information

Biomedical Accelerator Fund. Office of Technology Development Harvard University

Biomedical Accelerator Fund. Office of Technology Development Harvard University Biomedical Accelerator Fund Office of Technology Development Harvard University Curtis Keith, Chief Scientific Officer May 21, 2012 Mission of Harvard s Office 2 Organizational Structure of Harvard OTD

More information

Automating Cell Biology Annual general meeting, September 7, 2015. Phase Holographic Imaging www.phiab.se

Automating Cell Biology Annual general meeting, September 7, 2015. Phase Holographic Imaging www.phiab.se Automating Cell Biology Annual general meeting, September 7, 2015 www.phiab.se 1 PHASE HOLOGRAPHIC IMAGING (PHI) Began as a research project at Lund University, Sweden, in 2000 Founded in 2004 Sales in

More information

Dr. Muhammad Naveed Afzal MBBS, MD (USA), MPH (Johns Hopkins, USA) Fellowship, Health Services Research (Johns Hopkins University, USA) Director

Dr. Muhammad Naveed Afzal MBBS, MD (USA), MPH (Johns Hopkins, USA) Fellowship, Health Services Research (Johns Hopkins University, USA) Director Dr. Muhammad Naveed Afzal MBBS, MD (USA), MPH (Johns Hopkins, USA) Fellowship, Health Services Research (Johns Hopkins University, USA) Director It is the biggest reasons you go to a University. To learn.

More information

Investor Update. Roche posts very strong interim results. Basel, 20 July 2005

Investor Update. Roche posts very strong interim results. Basel, 20 July 2005 Investor Update Basel, 20 July 2005 Roche posts very strong interim results Roche Group Group sales up 17%. Pharmaceutical sales grow three times faster than the global market Operating profit rises 30%,

More information

Inform II. Quick Reference Guide. for Healthcare Professionals BLOOD GLUCOSE MONITORING SYSTEM

Inform II. Quick Reference Guide. for Healthcare Professionals BLOOD GLUCOSE MONITORING SYSTEM Inform II BLOOD GLUCOSE MONITORING SYSTEM Quick Reference Guide for Healthcare Professionals 2 Table of Contents Important... 4 General Information... 6 ACCU-CHEK Inform II Meter...10 How to Perform Patient

More information

Samsung POINT OF CARE Systems - Cardiac/Acute Care Biomarkers LABGEO IB Clinical Chemistry Analytes LABGEO PT

Samsung POINT OF CARE Systems - Cardiac/Acute Care Biomarkers LABGEO IB Clinical Chemistry Analytes LABGEO PT Samsung POINT OF CARE Systems - Cardiac/Acute Care Biomarkers LABGEO IB Clinical Chemistry Analytes LABGEO PT Alexander Belenky, PhD Director -Product Development Samsung - Nexus-Dx Edward Brennan, PhD

More information

Molecular Diagnostics: Accessories and Consumables

Molecular Diagnostics: Accessories and Consumables Molecular Diagnostics: Accessories and Consumables Catalog Number Packaging Reagent Description COBAS AMPLICOR Analyzer 21045636001 Box of 24 A-rings 28010447001 1 each A-ring holder 28008558001 1 set

More information

CASE STUDY. NHS Board. Contact. Email. Title. Category. Background/ context. NHS Tayside

CASE STUDY. NHS Board. Contact. Email. Title. Category. Background/ context. NHS Tayside NHS Board Contact Email NHS Tayside Dr Bill Bartlett (Consultant Clinical Scientist), Tejinder Chima (Clinical Services Manager) bill.bartlett@nhs.net, tchima@nhs.net Title Category Background/ context

More information

The Academy of Clinical Science and Laboratory Medicine Pathways to Fellowship

The Academy of Clinical Science and Laboratory Medicine Pathways to Fellowship The Academy of Clinical Science and Laboratory Medicine Revision 1 February 2015. Contents: 1 Introduction... 2 2 Constitution... 2 3 Qualification... 2 3.1 Accredited Masters Programmes... 3 3.2 Approved

More information

Clinical Chemistry Analyzers

Clinical Chemistry Analyzers Brochure More information from http://www.researchandmarkets.com/reports/562864/ Clinical Chemistry Analyzers Description: Clinical chemistry analysis is one of the most important areas within clinical

More information

Diagnostic and Medical Device Capabilities Boston Strategic Partners, Inc.

Diagnostic and Medical Device Capabilities Boston Strategic Partners, Inc. Diagnostic and Medical Device Capabilities Boston Strategic Partners is uniquely qualified to work with diagnostic and medical device companies on a variety of engagements Broad experiences with the diagnostic

More information

An important first step in identifying those at risk for Cardiovascular disease The Accutrend Plus system: from the makers of the ACCU-CHEK and

An important first step in identifying those at risk for Cardiovascular disease The Accutrend Plus system: from the makers of the ACCU-CHEK and An important first step in identifying those at risk for Cardiovascular disease The Accutrend Plus system: from the makers of the ACCU-CHEK and CoaguChek systems Cardiovascular disease: the #1 killer in

More information

Diagnostics: Growth through innovation and Personalised Healthcare. Daniel O Day, COO Roche Diagnostics

Diagnostics: Growth through innovation and Personalised Healthcare. Daniel O Day, COO Roche Diagnostics Diagnostics: Growth through innovation and Personalised Healthcare Daniel O Day, COO Roche Diagnostics Roche Diagnostics portfolio overview Industry leading businesses covering the entire IVD spectrum

More information

ehr Sharable Data Vicky Fung Senior Health Informatician ehr Information Standards Office

ehr Sharable Data Vicky Fung Senior Health Informatician ehr Information Standards Office ehr Sharable Data Vicky Fung Senior Health Informatician ehr Information Standards Office ehr - Vision DH HA epr Private Private Hospit als Hospitals EHR Repository Access Portal CMS onramp PPP Clinics

More information

A MULTIFACETED CYBERSECURITY APPROACH TO SAFEGUARD YOUR OPERATIONS

A MULTIFACETED CYBERSECURITY APPROACH TO SAFEGUARD YOUR OPERATIONS A MULTIFACETED CYBERSECURITY APPROACH TO SAFEGUARD YOUR OPERATIONS CYBER ATTACKS INFILTRATE CRITICAL INFRASTRUCTURE SECTORS Government and enterprise critical infrastructure sectors such as energy, communications

More information

Expert workflow management cobas p 312 pre-analytical system The new dimension of laboratory automation

Expert workflow management cobas p 312 pre-analytical system The new dimension of laboratory automation Expert workflow management cobas p 312 pre-analytical system The new dimension of laboratory automation Expert workflow management Concept Professional management of laboratory processes in terms of workflow

More information

Accu-Chek Connect Online diabetes management system. Setup Guide for Healthcare Providers

Accu-Chek Connect Online diabetes management system. Setup Guide for Healthcare Providers Accu-Chek Connect Online diabetes management system Setup Guide for Healthcare Providers Setup Accu-Chek Connect Online diabetes management system Welcome to the Accu-Chek Connect Online diabetes management

More information

Intelligent laboratory management Delivered by cobas IT middleware

Intelligent laboratory management Delivered by cobas IT middleware For technical specifications and additional information please see the enclosed datasheets. Intelligent laboratory management Delivered by cobas IT middleware To arrange a meeting or demonstration to learn

More information

Business Challenges Over the Past 40 Years

Business Challenges Over the Past 40 Years Special Feature 2: Business Challenges Over the Past 40 Years Sysmex started operating in 1968 to sell hematology analyzers manufactured by TOA Electric Co., Ltd. (now TOA Corporation). Sysmex has faced

More information

Roche R&D Center China (RRDCC) Media Visit to Roche in China Shanghai 30 October 2005 Andreas Tschirky, Ph.D. Head of Roche R&D Center (China) Ltd.

Roche R&D Center China (RRDCC) Media Visit to Roche in China Shanghai 30 October 2005 Andreas Tschirky, Ph.D. Head of Roche R&D Center (China) Ltd. Roche R&D Center China (RRDCC) Media Visit to Roche in China Shanghai 30 October 2005 Andreas Tschirky, Ph.D. Head of Roche R&D Center (China) Ltd. Roche recognizes changes in China Strong economic development

More information

TRI-LEVEL CARDIAC CONTROL (CRD CONTROL 1, 2, 3)

TRI-LEVEL CARDIAC CONTROL (CRD CONTROL 1, 2, 3) TRI-LEVEL CARDIAC CONTROL (CRD CONTROL 1, 2, 3) CAT NO. CQ3259 LOT NOS. 3190CK, 3191CK, 3192CK SIZE: 3 x 2ml EXPIRY: 2015-02 INTENDED USE This product is intended for in vitro diagnostic use in the quality

More information

From IMI to IMI2. Hugh Laverty PROTECT London

From IMI to IMI2. Hugh Laverty PROTECT London From IMI to IMI2 Hugh Laverty 20.02.2015 PROTECT London Innovative Medicines Initiative: Joining forces in the healthcare sector The biggest public/private partnership in Life Science aiming to: Make drug

More information

Annual General Meeting of Roche Holding Ltd 2 March 2010

Annual General Meeting of Roche Holding Ltd 2 March 2010 r Annual General Meeting of Roche Holding Ltd 2 March 2010 Address by Severin Schwan CEO of the Roche Group (Check against delivery.) Address by Severin Schwan Page 2 of 14 Ladies and Gentlemen, Fellow

More information

FDA approves Rituxan/MabThera for first-line maintenance use in follicular lymphoma

FDA approves Rituxan/MabThera for first-line maintenance use in follicular lymphoma Media Release Basel, 31 January 2011 FDA approves Rituxan/MabThera for first-line maintenance use in follicular lymphoma Approval provides option that improves the length of time people with incurable

More information

Committed to innovation and growth

Committed to innovation and growth Committed to innovation and growth Roland Diggelmann, COO Roche Diagnostics Bad Ragaz, 16 Jan 2015 Business model & strategy Q3 2014 overview Major products, launches and newsflow Building a leading sequencing

More information

Roche s marketing applications for review of OCREVUS (ocrelizumab) in two forms of multiple sclerosis accepted by EMA and FDA

Roche s marketing applications for review of OCREVUS (ocrelizumab) in two forms of multiple sclerosis accepted by EMA and FDA Media Release Basel, 28 June 2016 Roche s marketing applications for review of OCREVUS (ocrelizumab) in two forms of multiple sclerosis accepted by EMA and FDA OCREVUS is the first investigational medicine

More information

Roche Diagnostics Business Insight

Roche Diagnostics Business Insight Published by F. Hoffmann-La Roche Ltd Group Communications 4070 Basel, Switzerland Roche Diagnostics Business Insight 2014 All trademarks mentioned enjoy legal protection. www.roche.com 7 000 969 [Open

More information

Hospital Blood Glucose Testing Innovation with wireless connectivity

Hospital Blood Glucose Testing Innovation with wireless connectivity Hospital Blood Glucose Testing Innovation with wireless connectivity Content Savings thanks to wireless connectivity Instant information availability enabling process optimisation and cost savings. General

More information

Swiss Public Health Conference August, Basel Chronic diseases a global challenge

Swiss Public Health Conference August, Basel Chronic diseases a global challenge Federal Department of Foreign Affairs FDFA Swiss Agency for Development and Cooperation SDC The Director General Swiss Public Health Conference 2011 25-26 August, Basel Chronic diseases a global challenge

More information

IMI2: why, what, how?

IMI2: why, what, how? IMI2: why, what, how? The Right prevention and treatment, to the right patient, at the right time Isabelle Thizon-de Gaulle VP, Strategic initiatives & Scientific relations Sanofi R&D Innovative Medicines

More information

Effective Methods to Detect Current Security Threats

Effective Methods to Detect Current Security Threats terreactive AG. Swiss Cyber Storm 2015. Effective Methods to Detect Current Security Threats Taking your IT security to the next level, you have to consider a paradigm shift. In the past companies mostly

More information

J.P. Morgan Healthcare Conference 2014

J.P. Morgan Healthcare Conference 2014 January 13-16, 2014 J.P. Morgan Healthcare Conference 2014 Tecan Group AG Dr. David Martyr, CEO Safe Harbor Statement All statements in this presentation not referring to historical facts are predictions

More information

Aternity Mobile Wrapper. Overview and Use Cases

Aternity Mobile Wrapper. Overview and Use Cases Aternity Mobile Wrapper Overview and Use Cases Aternity Mobile Wrapper enables enterprises to instrument apps for diagnostics and user interactions no developer required! Assuring mobile workforce productivity

More information

Presented at: Jefferies 2015 Global Healthcare Conference

Presented at: Jefferies 2015 Global Healthcare Conference Presented at: Jefferies 2015 Global Healthcare Conference Agenda 1 Overview & Service Platforms 2 Adaptability, Scalability & Expansion Plans 3 Best Practices 4 Blue Chip Customer Base 5 Roadmap of Evolution

More information

Shifting paths of pharmaceutical innovation: Implications for the global pharmaceutical industry

Shifting paths of pharmaceutical innovation: Implications for the global pharmaceutical industry Shifting paths of pharmaceutical innovation: Implications for the global pharmaceutical industry Tariq Sadat PhD Candidate School of Economics, Finance and Marketing, RMIT University, Australia Roslyn

More information

Technology and Expertise Add Operational Value to Medical Device Trials

Technology and Expertise Add Operational Value to Medical Device Trials Technology and Expertise Add Operational Value to Medical Device Trials Copyright 2015 Medidata Solutions. Medidata Solutions and other trademarks reserved in the US and globally. Medidata and other marks

More information

cobas connection modules (CCM) Sample flow solutions for high-throughput laboratories

cobas connection modules (CCM) Sample flow solutions for high-throughput laboratories cobas connection modules (CCM) Sample flow solutions for high-throughput laboratories Expert workflow management The fast track to sample flow efficiency Professional management of laboratory processes

More information

Medical Laboratory Technology Program. Student Learning Outcomes & Course Descriptions with Learning Objectives

Medical Laboratory Technology Program. Student Learning Outcomes & Course Descriptions with Learning Objectives Medical Laboratory Technology Program Student Learning Outcomes & Course Descriptions with Learning Objectives Medical Laboratory Technology Student Learning Outcomes All Colorado Mesa University associate

More information

Diagnostics In 2009 sales again

Diagnostics In 2009 sales again Diagnostics In 2009 sales again grew well ahead of the market, with strong uptake of new products contributing to market share gains in key segments such as immunoassays and tissue diagnostics. All business

More information

ST. VINCENT'S. MEDICAL CENTER St. Vincent's Healthcare

ST. VINCENT'S. MEDICAL CENTER St. Vincent's Healthcare ST. VINCENT'S MEDICAL CENTER St. Vincent's Healthcare Medical Technology St. Vincent s Schools of Medical Science Throughout Northeast Florida and Southern Georgia, St. Vincent s HealthCare is well known

More information

cobas connection modules (CCM) Sample flow solutions for high-throughput laboratories

cobas connection modules (CCM) Sample flow solutions for high-throughput laboratories cobas connection modules (CCM) Sample flow solutions for high-throughput laboratories Expert workflow management The fast track to sample flow efficiency Professional management of laboratory processes

More information

The Geography of Markets for Technology: Evidence from Bio- Pharmaceuticals

The Geography of Markets for Technology: Evidence from Bio- Pharmaceuticals The Geography of Markets for Technology: Evidence from Bio- Pharmaceuticals Michelle Gittelman Department of Business and Management Rutgers Business School Newark-New Brunswick, New Jersey The pharmaceutical

More information

AdvaMedDx.org 4 EDMA and its Market Intelligence Activities EDMA Statistics Evolution Up to the late 80 s no harmonized IVD market statistics National trade associations in Europe established their own

More information

Global In-vitro Diagnostics Instruments Market

Global In-vitro Diagnostics Instruments Market Global In-vitro Diagnostics Instruments Market 2016-2020 No of Pages 101 Publishing Date - November 14, 2016 Browse detailed TOC, Tables, Figures, Charts in Global In-vitro Diagnostics Instruments Market

More information

Trends in IP strategy for young companies viewed from a larger company

Trends in IP strategy for young companies viewed from a larger company Trends in IP strategy for young companies viewed from a larger company Dr David Deperthes Vice President, BD&L, Debiopharm Int. CEO, Debiopharm Diagnostics Agenda General Information on Intellectual Property

More information

Evalution the multiplexed analysis of biomarkers made fast and simple by MyCartis

Evalution the multiplexed analysis of biomarkers made fast and simple by MyCartis Evalution the multiplexed analysis of biomarkers made fast and simple by MyCartis We are MyCartis Let s make healthcare personal The big revolution in healthcare today is that we are finally realizing

More information

Cyber Security: Software Security and Hard Drive Encryption

Cyber Security: Software Security and Hard Drive Encryption Links in this document have been set for a desktop computer with the resolution set to 1920 x 1080 pixels. Cyber Security: Software Security and Hard Drive Encryption 301-1497, Rev A September 2012 Copyright

More information

cobas 8100 automated workflow series 3-D intelligence in lab automation

cobas 8100 automated workflow series 3-D intelligence in lab automation cobas 8100 automated workflow series 3-D intelligence in lab automation Personalized Lab Automation Maximizing Testing Efficiency and Medical Value At Roche, laboratory automated solutions deliver the

More information

Wireless Technologies in Medical Devices: Market - IP Landscape

Wireless Technologies in Medical Devices: Market - IP Landscape 1.0 Background This document serves as a sample Market-IP analysis report. It proposes to provide the reader with information relating to the products in the market and in general to patent landscape analysis.

More information

We Innovate Healthcare

We Innovate Healthcare Part 2 Roche Annual Report 2007 Finance Report We Innovate Healthcare We Innovate Healthcare As a research-intensive healthcare company, Roche discovers, develops and provides innovative diagnostic and

More information

Introduction. The Healthcare Sector in Asia - Current Situation. Projected Healthcare Expenditure

Introduction. The Healthcare Sector in Asia - Current Situation. Projected Healthcare Expenditure Policy Issues in the Economics and Financing of Medical Technology in the Asia-Pacific Region Dr KAI HONG PHUA Joint Professor Yong Loo Lin School of Medicine and Lee Kuan Yew School of Public Policy National

More information

Next Generation Sequencing Informatics Markets

Next Generation Sequencing Informatics Markets Next Generation Sequencing Informatics Markets Greg Caressi SVP Healthcare & Life Sciences November, 2014 Personalization, Communication, Decentralization, Collaboration From... One Size Fits All APPROACH...To

More information

Healthcare Solid performance, strong perspectives Siemens Capital Market Day Berlin, December 9, 2014

Healthcare Solid performance, strong perspectives Siemens Capital Market Day Berlin, December 9, 2014 Hermann Requardt Member of the Managing Board & Healthcare CEO Healthcare Solid performance, strong perspectives Siemens Capital Market Day Notes and forward-looking statements This document contains statements

More information

Effective Methods to Detect Current Security Threats

Effective Methods to Detect Current Security Threats terreactive AG. Swiss Cyber Storm 2015. Effective Methods to Detect Current Security Threats Enrico Petrov Director Managed Security Services terreactive October 21 st, 2015 terreactive Background. About

More information

University Hospital Ulm Ulm, Germany. Prof. Dr. Dr. Dr. h.c. Max G. Bachem, Director Kerstin Stöhrer, Technical Supervisor

University Hospital Ulm Ulm, Germany. Prof. Dr. Dr. Dr. h.c. Max G. Bachem, Director Kerstin Stöhrer, Technical Supervisor University Hospital Ulm Ulm, Germany Prof. Dr. Dr. Dr. h.c. Max G. Bachem, Director Kerstin Stöhrer, Technical Supervisor The University Hospital Ulm was founded in 1982. In 30 years it has built an enviable

More information

FDA grants Roche s cancer immunotherapy Tecentriq (atezolizumab) accelerated approval for people with a specific type of advanced bladder cancer

FDA grants Roche s cancer immunotherapy Tecentriq (atezolizumab) accelerated approval for people with a specific type of advanced bladder cancer Media Release Basel, 19 May 2016 FDA grants Roche s cancer immunotherapy Tecentriq (atezolizumab) accelerated approval for people with a specific type of advanced bladder cancer First and only anti-pd-l1

More information

Special Feature: Growth Model of an Agile Company

Special Feature: Growth Model of an Agile Company Special Feature: Growth Model of an Agile Company 15 Sysmex s Global Strategy From the time of its establishment, Sysmex has followed a steady growth trajectory, and the Group now provides products and

More information

September 29, About BIO

September 29, About BIO The Comments of the Biotechnology Industry Organization on the Discussion Paper on Compulsory Licenses Published by the Department of Industrial Policy and Promotion within India's Ministry of Commerce

More information

Diagnostic Detectives: Medical Laboratory Professionals. A Closer Look at Careers in Clinical Laboratory Science (Medical Technology)

Diagnostic Detectives: Medical Laboratory Professionals. A Closer Look at Careers in Clinical Laboratory Science (Medical Technology) Diagnostic Detectives: Medical Laboratory Professionals A Closer Look at Careers in Clinical Laboratory Science (Medical Technology) Medical Laboratory Facts A behind-the the-scenes, highly skilled team

More information

Hospital Clinic de Barcelona Advances Its Hemostasis and Hematology Workflow with Aptio Automation

Hospital Clinic de Barcelona Advances Its Hemostasis and Hematology Workflow with Aptio Automation Case Study www.siemens.com/diagnostics Hospital Clinic de Barcelona Advances Its Hemostasis and Hematology Workflow with Aptio Automation Answers for life. We ve undergone two revolutions: initially in

More information

Public-Private Partnerships for Bridging the Innovation Gap in Personalized Medicine

Public-Private Partnerships for Bridging the Innovation Gap in Personalized Medicine Public-Private Partnerships for Bridging the Innovation Gap in Personalized Medicine Martin LeBlanc, President and CEO, Caprion The 2014 ISPIM Americas Innovation Forum October 6, 2014 1 CHALLENGES FOR

More information

Our values help us to create added value in a sustainable way. Sustainability includes fostering and retaining our most talented employees

Our values help us to create added value in a sustainable way. Sustainability includes fostering and retaining our most talented employees Our values help us to create added value in a sustainable way Sustainability includes fostering and retaining our most talented employees 32 Sustainability Report 2004 Creating value through sustainable

More information

Health Data Cooperatives Citizen-Controlled Health Data Repositories as a Basis for Big Data Analytics in Health

Health Data Cooperatives Citizen-Controlled Health Data Repositories as a Basis for Big Data Analytics in Health Health Data Cooperatives Citizen-Controlled Health Data Repositories as a Basis for Big Data Analytics in Health ehealth2014 May 12-14 2014, Athens Prof. Ernst Hafen Behavior Health Drugs Therapy Genome

More information